Michael Ryskin
Stock Analyst at Bank of America Securities
(3.36)
# 2,336
Out of 4,455 analysts
670
Total ratings
51.4%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Reiterated: Sell | $125 → $150 | $169.86 | -11.69% | 21 | Jun 24, 2026 | |
| ZTS Zoetis | Maintained: Hold | $108 | $76.09 | +41.94% | 43 | Jun 16, 2026 | |
| DHR Danaher | Reiterated: Buy | $270 | $196.19 | +37.62% | 39 | Jun 11, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | n/a | $215.75 | - | 19 | Jun 5, 2026 | |
| PAHC Phibro Animal Health | Maintained: Sell | $38 | $31.69 | +19.91% | 14 | Jun 5, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | $30 → $32 | $24.57 | +30.24% | 35 | Jun 5, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $145 → $155 | $136.01 | +13.96% | 24 | Jun 2, 2026 | |
| BRKR Bruker | Reiterated: Buy | $65 | $60.91 | +6.71% | 25 | Jun 2, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $630 | $513.03 | +22.80% | 29 | Jun 2, 2026 | |
| WAT Waters | Reiterated: Hold | $370 → $400 | $374.41 | +6.83% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $350.85 | - | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 | $56.14 | +14.00% | 15 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $175 | $178.43 | -1.92% | 24 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 | $176.55 | -43.36% | 46 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $113.02 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.75 | - | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $39.41 | +24.33% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 | $191.14 | +28.18% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $18.50 | +51.35% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $27 | $26.67 | +1.24% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,263.75 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $5.88 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.74 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $135 | $149.22 | -9.53% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.86 | - | 22 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $9.5 | $17.65 | -46.18% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $790 → $660 | $551.50 | +19.67% | 31 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $11 | $14.17 | -22.37% | 13 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $209.88 | +7.20% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $295 | $271.47 | +8.67% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $28 | $17.84 | +56.95% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $10.28 | +7.00% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $6.22 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $5.84 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $10.25 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $10.89 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.52 | n/a | 2 | Apr 18, 2022 |
ICON Public Limited Company
Jun 24, 2026
Reiterated: Sell
Price Target: $125 → $150
Current: $169.86
Upside: -11.69%
Zoetis
Jun 16, 2026
Maintained: Hold
Price Target: $108
Current: $76.09
Upside: +41.94%
Danaher
Jun 11, 2026
Reiterated: Buy
Price Target: $270
Current: $196.19
Upside: +37.62%
Charles River Laboratories International
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $215.75
Upside: -
Phibro Animal Health
Jun 5, 2026
Maintained: Sell
Price Target: $38
Current: $31.69
Upside: +19.91%
Elanco Animal Health
Jun 5, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $24.57
Upside: +30.24%
Agilent Technologies
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $136.01
Upside: +13.96%
Bruker
Jun 2, 2026
Reiterated: Buy
Price Target: $65
Current: $60.91
Upside: +6.71%
Thermo Fisher Scientific
Jun 2, 2026
Maintained: Buy
Price Target: $630
Current: $513.03
Upside: +22.80%
Waters
Jun 2, 2026
Reiterated: Hold
Price Target: $370 → $400
Current: $374.41
Upside: +6.83%
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $350.85
Upside: -
Jun 1, 2026
Maintained: Hold
Price Target: $64
Current: $56.14
Upside: +14.00%
May 27, 2026
Maintained: Sell
Price Target: $175
Current: $178.43
Upside: -1.92%
May 14, 2026
Maintained: Sell
Price Target: $100
Current: $176.55
Upside: -43.36%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $113.02
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $36.75
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $39.41
Upside: +24.33%
May 13, 2026
Maintained: Buy
Price Target: $245
Current: $191.14
Upside: +28.18%
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $18.50
Upside: +51.35%
May 12, 2026
Initiated Coverage: Hold
Price Target: $27
Current: $26.67
Upside: +1.24%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1,263.75
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $5.88
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $2.74
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $120 → $135
Current: $149.22
Upside: -9.53%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $16.86
Upside: -
May 6, 2026
Reiterated: Sell
Price Target: $8 → $9.5
Current: $17.65
Upside: -46.18%
May 5, 2026
Maintained: Hold
Price Target: $790 → $660
Current: $551.50
Upside: +19.67%
Apr 29, 2026
Maintained: Hold
Price Target: $13 → $11
Current: $14.17
Upside: -22.37%
Apr 21, 2026
Maintained: Buy
Price Target: $225
Current: $209.88
Upside: +7.20%
Apr 7, 2026
Maintained: Buy
Price Target: $295
Current: $271.47
Upside: +8.67%
Mar 4, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $17.84
Upside: +56.95%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $10.28
Upside: +7.00%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $6.22
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $5.84
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $10.25
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $10.89
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.52
Upside: n/a